At the 2025 MOASC Spotlight in Newport Beach, CA, Dr. Miguel Villalona-Calero, MD, from the University of California Irvine, shared key ASCO 2025 lung cancer advances. His OncologyTube interview and slide deck highlight progress in small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). For example, trials like NeoADAURA, DeLLphi-304, and KRYSTAL-7 show … Continue reading What are the latest updates on Tarlatamab, NeoADAURA, key lung cancer treatments from ASCO 2025?